Marvell Technology (MRVL) 4: Koopmans Chris bought 56,232 shares of Common Stock at $N/A… (May 19, 2026)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-05-15 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Marvell Technology, Inc. (MRVL) CIK: 0001835632 --- Reporting Owner --- Name: Koopmans Chris CIK: 0001676204 Role: Officer (President and COO) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-05-15 | Code: M (Exercise of derivative) Shares: +56,232 | Price: $0.00 Shares Owned After: 265,824 | Ownership: I (Indirect) | Nature: By Trust Footnotes: [F1] Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust. [Transaction #2] Security: Common Stock Date: 2026-05-15 | Code: F (Payment of exercise/tax) Shares: -27,882 | Price: $176.89 Total Value: $4,932,046.98 Shares Owned After: 237,942 | Ownership: I (Indirect) | Nature: By Trust Footnotes: [F2] Surrender of shares in payment of tax withholding due as a result of the vesting of performance stock units. [F1] Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust. --- Derivative Transactions --- [Transaction #1] Security: Performance Stock Units Date: 2026-05-15 | Code: M (Exercise of derivative) Shares: -56,232 | Price: $0.00 Shares Owned After: 78,098 | Ownership: D (Direct) Footnotes: [F3] Each performance stock unit represents a contingent right to receive one share of Common Stock of Marvell Technology, Inc. upon vesting. [F4] This performance stock unit award included stock price and total stockholder return-based performance criteria and was structured in four tranches tied to stock price targets of $60, $80, $100, and $120, with a TSR modifier applicable to the award. The performance conditions for the $60 tranche, the $80 tranche, and the $100 tranche were certified on August 22, 2023, December 5, 2024, and January 24, 2025, respectively. As a result, the three certified tranches became subject to a service-based vesting condition pursuant to which 50% of the shares vested on May 15, 2026 and 50% of the shares will vest on May 15, 2028 (subject to continued service to the company). The performance criteria for the remaining tranche tied to the $120 stock price target have not yet been certified. [F4] This performance stock unit award included stock price and total stockholder return-based performance criteria and was structured in four tranches tied to stock price targets of $60, $80, $100, and $120, with a TSR modifier applicable to the award. The performance conditions for the $60 tranche, the $80 tranche, and the $100 tranche were certified on August 22, 2023, December 5, 2024, and January 24, 2025, respectively. As a result, the three certified tranches became subject to a service-based vesting condition pursuant to which 50% of the shares vested on May 15, 2026 and 50% of the shares will vest on May 15, 2028 (subject to continued service to the company). The performance criteria for the remaining tranche tied to the $120 stock price target have not yet been certified. --- Footnotes (Complete Index) --- F1: Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust. F2: Surrender of shares in payment of tax withholding due as a result of the vesting of performance stock units. F3: Each performance stock unit represents a contingent right to receive one share of Common Stock of Marvell Technology, Inc. upon vesting. F4: This performance stock unit award included stock price and total stockholder return-based performance criteria and was structured in four tranches tied to stock price targets of $60, $80, $100, and $120, with a TSR modifier applicable to the award. The performance conditions for the $60 tranche, the $80 tranche, and the $100 tranche were certified on August 22, 2023, December 5, 2024, and January 24, 2025, respectively. As a result, the three certified tranches became subject to a service-based vesting condition pursuant to which 50% of the shares vested on May 15, 2026 and 50% of the shares will vest on May 15, 2028 (subject to continued service to the company). The performance criteria for the remaining tranche tied to the $120 stock price target have not yet been certified. --- Signature --- /s/ Christopher Koopmans by Blair Walters as Attorney-in-Fact (2026-05-19)